J 2021

Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study

HANSEN, C. S., M. E. JORGENSEN, Marek MALÍK, D. R. WITTE, E. J. BRUNNER et. al.

Základní údaje

Originální název

Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study

Autoři

HANSEN, C. S. (garant), M. E. JORGENSEN, Marek MALÍK (203 Česká republika, domácí), D. R. WITTE, E. J. BRUNNER, A. G. TABAK, M. KIVIMAKI a D. VISTISEN

Vydání

DIABETES CARE, ALEXANDRIA, AMER DIABETES ASSOC, 2021, 0149-5992

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30202 Endocrinology and metabolism

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 17.152

Kód RIV

RIV/00216224:14110/21:00121368

Organizační jednotka

Lékařská fakulta

UT WoS

000630755000030

Klíčová slova anglicky

Heart Rate; Cardiovascular Disease; Dysglycemia

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 7. 4. 2021 13:31, Mgr. Tereza Miškechová

Anotace

V originále

OBJECTIVE Higher resting heart rate (rHR) and lower heart rate variability (HRV) are associated with increased risk of cardiovascular disease (CVD) and all-cause mortality in people with and without diabetes. It is unknown whether temporal changes in rHR and HRV may contribute to this risk. We investigated associations between 5-year changes in rHR and HRV and risk of future CVD and death, taking into account participants' baseline glycemic state. RESEARCH DESIGN AND METHODS In this prospective, population-based cohort study we investigated 4,611 CVD-free civil servants (mean [SD] age, 60 [5.9] years; 70% men). We measured rHR and/or six indices of HRV. Associations of 5-year change in 5-min rHR and HRV with fatal and nonfatal CVD and all-cause mortality or the composite of the two were assessed, with adjustments made for relevant confounders. Effect modification by glycemic state was tested. RESULTS At baseline, 63% of participants were normoglycemic, 29% had prediabetes, and 8% had diabetes. During a median (interquartile range) follow-up of 11.9 (11.4; 12.3) years, 298 participants (6.5%) experienced a CVD event and 279 (6.1%) died of non-CVD-related causes. We found no association between 5-year changes in rHR and HRV and future events. Only baseline rHR was associated with all-cause mortality. A 10 bpm-higher baseline HR level was associated with an 11.4% higher rate of all-cause mortality (95% CI 1.0-22.9%; P = 0.032). Glycemic state did not modify associations. CONCLUSIONS Changes in rHR and HRV and possibly also baseline values of these measures are not associated with future CVD or death in people with or without dysglycemia.